Filter
473
Filtered Results: 473
Text search:
pyrazinamide
Featured
Recommendations
70
New Publications
131
Language
Document type
No document type
318
Guidelines
79
Manuals
26
Studies & Reports
22
Training Material
12
Strategic & Response Plan
7
Fact sheets
7
Situation Updates
2
Countries / Regions
Western and Central Europe
25
India
25
Nepal
14
Eastern Europe
12
Argentina
11
Kenya
10
Senegal
8
Peru
8
Tanzania
8
Bangladesh
8
Ethiopia
8
South Africa
7
Uganda
7
Malawi
6
Germany
6
Paraguay
6
Indonesia
6
Ukraine
5
Bolivia
5
Zambia
5
Colombia
4
Nigeria
4
Philippines
4
Mozambique
4
Cambodia
4
Brazil
4
Russia
4
Namibia
4
El Salvador
3
Lesotho
3
Ghana
3
Rwanda
3
Latin America and the Carribbean
3
Congo, Democratic Republic of
3
Botswana
3
Ecuador
3
Myanmar / Burma
3
Eswatini/ Swaziland
3
Benin
2
Cameroon
2
Burkina Faso
2
Zimbabwe
2
Haiti
2
Tajikistan
1
Switzerland
1
Gambia
1
Chile
1
Malaysia
1
Asia
1
Venezuela
1
South–East Asia Region
1
Eastern Europe and Central Asia
1
Uruguay
1
Romania
1
Central African Republic
1
Chad
1
Libya
1
Bhutan
1
Liberia
1
Solomon Islands
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
215
Clinical Guidelines
71
Public Health
7
Women & Child Health
7
Pharmacy & Technologies
4
Capacity Building
3
Key Resources
1
Toolboxes
TB
252
Pharmacy
33
HIV
29
Refugee
9
AMR
6
COVID-19
5
Caregiver
5
Polio
5
NTDs
4
Ebola & Marburg
3
Mental Health
1
Natural Hazards
1
Conflict
1
Zika
1
This rapid communication outlines the main outcomes of a WHO convened Guideline Development Group (GDG) meeting, held in May-June 2021 on the topic of the management of TB in children and adolescents. The rapid communication aims to inform staff from ministries of health and care providers across p...
This 2011 update of Guidelines for the programmatic management of drug-resistant tuberculosis is intended as a tool for use by public health professionals working in response
to the Sixty-second World Health Assembly’s resolution on prevention and control of multidrug-resistant tuberculosis and e...
International Journal of Drug Policy 24 (2013) e91-98
Prise en charge Intégrée des maladies de l’adolescent
et de l’adulte (PCIMAA)
Avril 2007
WHO/HTM/VIH/2007.01
WHO/HTM/TB/2007.380
WHO/CDS/TB/99.272
Distr.: General, Original: French
Troisième édition 2016
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
4th edition.
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of key DR-TB drugs, using manufacturer responses to s...
TB remains one of the world’s deadliest infectious diseases, second only to COVID-19, and drug-resistant TB strains are still a major concern. In the fight against TB, urgent investment is critical, especially in the context of the ongoing pandemic.
Malawi Integrated Guidelines and Standard Operating Procedures for Providing HIV Services. 3rd edition 2016
Solomon Islands pharmacy staff have developed an essential medicines supplies list. It was a collaborative effort involving a lot of staff taking the pictures and putting it all together. The list was launched as an initiative to improve the availability of medical stock within the country
The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB, ...
